Literature DB >> 8396591

Relative frequency of VP4 gene alleles among human rotaviruses recovered over a 10-year period (1982-1991) from Japanese children with diarrhea.

S Gunasena1, O Nakagomi, Y Isegawa, E Kaga, T Nakagomi, A D Steele, J Flores, S Ueda.   

Abstract

The relative frequencies of the Wa (corresponding to serotype P1A), DS-1(P1B), M37(P2), and AU-1(P3) alleles of the VP4 gene from rotaviruses collected from the stools of individuals in Japan between 1982 and 1991 were determined to be 83.1, 15.6, 0, and 1.3%, respectively, by a polymerase chain reaction-based typing assay.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8396591      PMCID： PMC265721          DOI： 10.1128/jcm.31.8.2195-2197.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

Review 1.  Rotavirus vaccines.

Authors:  J Flores; A Z Kapikian
Journal:  Biotechnology       Date:  1992

2.  Distribution of serotypes of human rotavirus in different populations.

Authors:  P A Woods; J Gentsch; V Gouvea; L Mata; M Santosham; Z S Bai; S Urasawa; R I Glass
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Molecular evidence for naturally occurring single VP7 gene substitution reassortant between human rotaviruses belonging to two different genogroups.

Authors:  O Nakagomi; T Nakagomi
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Improved detection of rotavirus RNA in dot-blot hybridization assay by chromatographic extraction and acid denaturation of double-stranded RNA.

Authors:  K Yamakawa; O Nakagomi
Journal:  Mol Cell Probes       Date:  1990-10       Impact factor: 2.365

Review 5.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

6.  Occurrence of changes in human rotavirus serotypes with concurrent changes in genomic RNA electropherotypes.

Authors:  T Nakagomi; K Akatani; N Ikegami; N Katsushima; O Nakagomi
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

7.  Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.

Authors:  Y Hoshino; M M Sereno; K Midthun; J Flores; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Identification of the two rotavirus genes determining neutralization specificities.

Authors:  P A Offit; G Blavat
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

9.  Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.

Authors:  M Gorziglia; G Larralde; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

10.  A VP4 sequence highly conserved in human rotavirus strain AU-1 and feline rotavirus strain FRV-1.

Authors:  Y Isegawa; O Nakagomi; T Nakagomi; S Ueda
Journal:  J Gen Virol       Date:  1992-08       Impact factor: 3.891
View more
  21 in total

1.  Development of a microtiter plate hybridization-based PCR-enzyme-linked immunosorbent assay for identification of clinically relevant human group A rotavirus G and P genotypes.

Authors:  Norma Santos; Shinjiro Honma; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

2.  Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes.

Authors:  Shinjiro Honma; Vladimir Chizhikov; Norma Santos; Masatoshi Tatsumi; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Joana D'Arc P Mascarenhas; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

3.  Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types).

Authors:  P J Masendycz; E A Palombo; R J Gorrell; R F Bishop
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

4.  Prevalence of G and P serotypes among equine rotaviruses in the faeces of diarrhoeic foals.

Authors:  G F Browning; A P Begg
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999.

Authors:  N A Cunliffe; J S Gondwe; S M Graham; B D Thindwa; W Dove; R L Broadhead; M E Molyneux; C A Hart
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  Molecular characterization of VP7 gene of human rotaviruses from Bangladesh.

Authors:  Kamruddin Ahmed; Selim Ahmed; Marcelo Takahiro Mitui; Aminur Rahman; Luthful Kabir; Abdul Hannan; Akira Nishizono; Osamu Nakagomi
Journal:  Virus Genes       Date:  2010-03-10       Impact factor: 2.332

7.  Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain.

Authors:  Ryuichi Uchida; Basu Dev Pandey; Jeevan Bahadur Sherchand; Kamurddin Ahmed; Michiyo Yokoo; Toyoko Nakagomi; Luis E Cuevas; Nigel A Cunliffe; C A Hart; Osamu Nakagomi
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

8.  Recurrent circulation of single nonstructural gene substitution reassortants among human rotaviruses with a short RNA pattern.

Authors:  E Kaga; O Nakagomi
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Distribution of both rotavirus VP4 genotypes and VP7 serotypes among hospitalized and nonhospitalized Israeli children.

Authors:  I Silberstein; L M Shulman; E Mendelson; I Shif
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Rotaviruses belonging to the AU-1 genogroup recovered from Israeli infants with diarrhea.

Authors:  I Shif; M Iizuka; I Silberstein; E Mendelson; O Nakagomi
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.